As a result of incretins’ ability to increase insulin production from pancreatic β cells following eating, blood insulin levels were lowered, and postprandial hyperglycemia was subsequently enhanced when bacterial DPP-4 restricted the proteolysis of incretins. The gene discussed is DPP4; the disease is Hyperglycemia.